SPONSOR:  Maze Therapeutics 

INDICATION:  Chronic Kidney Disease 

STUDY:  MZE829-201:  An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype 

LOCATION: GEORGIA

SPONSOR:  Coologics, Inc. 

INDICATION:  Vulvovaginal Candidiasis (VVC) 

STUDY:  Open-label, Uncontrolled Clinical Research Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) 

LOCATION: GEORGIA

SPONSOR:  Merck Sharp & Dohme LLC

INDICATION: COVID-19

STUDY: 023-02:

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression

LOCATION: GEORGIA

SPONSOR:  Otsuka Pharmaceutical Development & Commercialization, Inc.

INDICATION: MAJOR DEPRESSIVE DISORDER

STUDY: A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment of Adults with Major Depressive Disorder

LOCATION: GEORGIA